This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Cystic fibrosis (CF) - related diabetes

Authoring team

Diagnose cystic fibrosis-related diabetes using one of the following:

  • continuous glucose monitoring (CGM)
  • serial glucose testing over several days
  • oral glucose tolerance testing (OGTT) - if OGTT is abnormal perform CGM or serial glucose testing over several days to confirm the diagnosis.

Test for cystic-fibrosis-related diabetes

  • in people with cystic fibrosis annually from 10 years of age
  • at the end of the first and second trimesters of pregnancy, using CGM or OGTT
  • in people with cystic fibrosis who are taking long-term systemic corticosteroids or receiving enteral tube feeding, using CGM or serial glucose monitoring.

Consider testing for cystic-fibrosis-related diabetes in people who still have any of the following despite optimised cystic fibrosis treatment:

  • unexplained weight loss
  • a deterioration in lung function as measured by spirometry
  • increased frequency of pulmonary exacerbations
  • excessive tiredness.

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.